Table of Contents
SGLT2 inhibitors, such as Canagliflozin, are a class of medications primarily used to treat type 2 diabetes. They work by targeting a specific protein in the kidneys to help control blood sugar levels more effectively.
What Are SGLT2 Inhibitors?
SGLT2 inhibitors block the sodium-glucose co-transporter 2 (SGLT2) protein located in the proximal tubules of the kidneys. This protein is responsible for reabsorbing glucose from urine back into the bloodstream.
How Does Canagliflozin Work?
Canagliflozin inhibits SGLT2, reducing glucose reabsorption. As a result, excess glucose is excreted in the urine, leading to lower blood sugar levels. This process also helps reduce body weight and blood pressure in some patients.
Benefits of SGLT2 Inhibitors
- Lower blood glucose levels
- Reduce body weight
- Lower blood pressure
- Decrease risk of cardiovascular events
Potential Side Effects
While effective, SGLT2 inhibitors can cause side effects such as urinary tract infections, dehydration, and in rare cases, ketoacidosis. Patients should be monitored regularly by healthcare providers.
Conclusion
Understanding the mechanism of SGLT2 inhibitors like Canagliflozin helps in appreciating their role in managing type 2 diabetes. Their ability to promote glucose excretion offers a valuable tool in controlling blood sugar and improving overall health outcomes.